The laboratory directed by Bruno Giros, PhD, studies the molecular networks of dopamine and glutamate receptors and transporters, two neurotransmitters that play a key role in schizophrenia.

The laboratory’s focus is on the neurons that use glutamate, an excitatory neurotransmitter that is key to the functioning of the central nervous system.

Bruno Giros characterizes the neurobiology of schizophrenia and develops improved genetic animal models of this illness.

Ng Ying Kin uses neurochemical analyses to identify peripheral biological markers for various psychiatric disorders.

Work from Rémi Quirion's lab has helped to characterize the roles of cholinergic synapses in Alzheimer Disease, neuropeptide Y in depression and learning, and calcitonin gene-related peptide (CGRP) in pain and opioid tolerance.

Salah El Mestikawy studies neurons using glutamate as a neurotransmitter in healthy and diseased central nervous systems.  

Congratulations to Rémi Quirion, PhD, on being named Officer of the Order of Canada

"Bilingual" neurons may reveal the secrets of brain disease

Directed by N.M.K. Ng Ying Kin, PhD, the laboratory measures putative biological markers for various psychiatric conditions and treatment-resistance to usual medications.

Depression in young people is considered a disorder when feelings of sadness, emptiness, etc. last for many days and significantly impair life.